Abstract: A dialogue system includes a storage device and an execution device. Scenario data stored in the storage device define a response sentence corresponding to a state and a transition condition for transition to a different state. The execution device executes a text data generation process, a determination process, a scenario response process, a chat process, a storage process, and a return process. The text data generation process is a process of converting a voice of a user into text data. The determination process is a process of determining whether the transition condition is satisfied. The scenario response process is a process of operating a speaker so as to make a response when the transition condition is satisfied. The chat process is a process of operating the speaker so as to make a different response when the transition condition is not satisfied.

Abstract: A dialogue system that dialogues with a user includes an execution device configured to execute a detection process and a recognition process. The recognition process is a process of recognizing that the user talks to the dialogue system when a predetermined state is detected by the detection process. The detection process is a process of detecting the predetermined state using, as an input, an output signal of a camera that images the user. The predetermined state includes a state in which a mouth of the user moves.

Abstract: This invention relates to a pharmaceutical comprising as an effective ingredient an arylmethylene urea exemplified by the following formula: or a pharmaceutically acceptable salt thereof. The arylmethylene urea and the pharmaceutically acceptable salts thereof are useful for therapy or prophylaxis of inflammatory bowel disease and overactive bladder.

Abstract: The compounds of the disclosure, for example, the compound represented by the formula: has excellent therapeutic and prophylactic effects against inflammatory bowel disease. Further, they are excellent in absorption and in vivo stability when administered orally in comparison with conventional compounds. That is, the compounds can be administered orally, and can have excellent therapeutic or prophylactic effect sustained for a longer period of time.

Abstract: A glycine derivative which is, e.g., the following compound (Chemical formula (1)). It is highly effective in the treatment and prevention of inflammatory bowel diseases. Compared to conventional compounds, the compound is excellent in absorbability in oral administration and in vivo stability. The compound can be orally administered and can retain an excellent therapeutic or preventive effect over a longer period.